Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M112Revenue $M39.2Net Margin (%)-4.6Altman Z-Score11.6
Enterprise Value $M16.2EPS $-0.2Operating Margin %-2.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score4.3Pre-tax Margin (%)-9.0Higher ROA y-yN
Price/Book1.010-y EBITDA Growth Rate %--Quick Ratio13.5Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %--Current Ratio15.2Lower Leverage y-yY
Price/Free Cash Flow20.6y-y EBITDA Growth Rate %-66.7ROA % (ttm)-1.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-1.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M9.5ROIC % (ttm)-2.2Gross Margin Increase y-yN

Gurus Latest Trades with GENC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GENCJohn Keeley 2010-03-31 Sold Out $6.9 - $7.8
($7.31)
$ 11.7160%Sold Out0
GENCJohn Keeley 2009-09-30 Buy $6.38 - $8.35
($7.23)
$ 11.7162%New holding30,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GENC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GENC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ELLIOTT MARC GPresident 2015-12-15Sell19,044$12.74-8.08view
Houtkin Sherry10% Owner 2015-10-06Sell80,000$9.2626.46view
Houtkin Sherry10% Owner 2015-05-06Sell70,000$9.227.28view
LYONS JEANNE MSecretary 2015-03-16Sell985$9.7819.73view
LYONS JEANNE MSecretary 2015-03-16Sell985$9.7819.73view
Houtkin Sherry10% Owner 2014-12-08Sell2,948$9.7220.47view
Houtkin Sherry10% Owner 2014-12-02Sell5,000$9.9317.93view
Houtkin Sherry10% Owner 2014-11-25Sell200,000$9.2526.59view
Houtkin Sherry10% Owner 2014-09-04Sell29$10.1914.92view
Houtkin Sherry10% Owner 2014-09-02Sell5,000$10.1815.03view

Quarterly/Annual Reports about GENC:

News about GENC:

Articles On GuruFocus.com
Winning with the Net Current Asset Value Approach to Stocks Sep 04 2013 
Ben Graham Net-Net Newsletter: TSR (TSRI) One Year Later Apr 09 2012 
“Assign Yourself the Right Story” Mar 05 2012 
Ben Graham Net-Net Newsletter: Gencor (GENC) One Year Later Feb 29 2012 
How Long Should You Hold a Net-Net? Feb 13 2012 
Opt-Sciences $OPST- Follow Up Feb 01 2012 
Four Stocks to Fit in a Basket of Negative Enterprise Value with Certain Profitability Dec 23 2011 
Gencor ($GENC)- A free business with a huge portfolio Dec 22 2011 
Genco Industries: $15 Million in Cash and the Company for Free Sep 28 2011 
Gencor Industries Inc. Reports Operating Results (10-Q) Aug 13 2010 

More From Other Websites
Genmab Announces U.S. FDA Approval of Arzerra® (ofatumumab) as Extended Treatment for Recurrent or... Jan 19 2016
Daratumumab Data Published in The Lancet Shows Encouraging Efficacy in Heavily Pretreated and... Jan 07 2016
Genmab Achieves $3 Million Milestone in DuoBody Platform Collaboration with Janssen Dec 21 2015
Genmab Announces Completion of Agreement to Transfer Remaining Ofatumumab Rights Dec 21 2015
Genmab Achieves $3 Million Milestone for Progress in DuoBody Platform Collaboration with Janssen Dec 18 2015
Articles of Association for Genmab A/S Dec 18 2015
Genmab to Present at the 34th Annual J.P. Morgan Healthcare Conference Dec 15 2015
GENCOR INDUSTRIES INC Financials Dec 12 2015
Report Pursuant to Section 28a of the Danish Securities Trading Act Dec 10 2015
Grant of Restricted Stock Units to Board Members and Management and Grant of Warrants to Management... Dec 10 2015
GENCOR RELEASES FOURTH QUARTER AND FISCAL YEAR 2015 RESULTS Dec 09 2015
Gencor Industries, Inc.: Leading performance but fundamentals not looking strong? Dec 09 2015
Genmab Achieves USD 5 Million Milestone in Daratumumab Collaboration with Janssen Dec 09 2015
GENCOR INDUSTRIES INC Files SEC form 10-K, Annual Report Dec 09 2015
GENCOR INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Dec 09 2015
Gencor reports 4Q loss Dec 08 2015
Gencor reports 4Q loss Dec 08 2015
Gencor Releases Fourth Quarter and Fiscal Year 2015 Results Dec 08 2015
Genmab's 2015 R&D Update Live from Orlando Dec 08 2015
Genmab to Hold R&D Update on Company's Progress in 2015 Dec 04 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK